Description
Thymalin is a complex of polypeptides extracted from calf thymus and established in the Khavinson bioregulator school as a central compound for immune research. In contrast to synthetic mono-peptides like thymosin alpha-1 or KPV, thymalin is a defined multi-peptide mixture used in Russian research tradition since the 1970s as an immune modulator.
The research mechanism is multimodal. Thymalin contains multiple low-molecular peptides associated in preclinical studies with effects on T-cell differentiation, immune cell activation and thymic function. In animal models, thymalin has been described with restoration of age-related reduced thymus function, also making the compound interesting in anti-aging research contexts.
A particularity of thymalin: the compound data largely originates from Russian-language research literature, which has reduced international visibility. The Khavinson school at the St. Petersburg Institute of Bioregulation and Gerontology has produced substantial research on bioregulator peptides, placing thymalin in a broader research context with other Khavinson peptides (epitalon, pinealon, cerebrolysin, etc.).
In research setups, thymalin is complementary to synthetic immune compounds. The multi-component nature allows broader mechanism coverage but reduces mechanistic clarity compared to mono-peptide research.
Thymalin is available in 10mg vials as 10-vial packs.
This information is for research and educational purposes only. No medical recommendations.
Risks & Safety
Thymalin is considered well tolerated per study reports and has been used in the Russian bioregulator tradition since the 1970s as an immune modulator.
Observed in research and user reports:
- Injection site: mild redness or pressure at the injection site is the most common local observation, typical for subcutaneously applied peptides.
- Immune modulation: thymalin modulates T-cell differentiation and thymic function in preclinical studies, an active intervention in adaptive immunity.
- Calf origin and variable composition: thymalin is a multi-peptide mixture extracted from calf thymus rather than a defined mono-peptide, which limits batch-to-batch consistency and mechanistic clarity.
- Data base: the evidence comes predominantly from Russian-language research literature. Robust international long-term human data are largely lacking.
This classification does not replace medical advice. Risk and responsibility for any actual use lie entirely with the buyer.
Studies
- Natural and synthetic thymic peptides as therapeutics for immune dysfunction - International Journal of Immunopharmacology 1997: Describes thymalin as a peptide extract from calf thymus and the dipeptide Glu-Trp isolated from it: in the experiments both activated T-cell differentiation and altered cytokine release from blood lymphocytes.
- Thymalin: Activation of Differentiation of Human Hematopoietic Stem Cells - Bulletin of Experimental Biology and Medicine 2020: In human hematopoietic stem cells, thymalin reduced expression of CD44 and CD117 two- to threefold and increased the T-cell marker CD28 6.8-fold, an indirect indication of promoted differentiation.
- Peptide bioregulation of aging: results and prospects - Biogerontology 2010: Review from the bioregulator school on peptide preparations from organs and their synthetic analogues: reports longer mean life spans and fewer tumors in rodents, based on the authors’ own long-term work.
